"doctype","doctypestr","doctypedesc","tecode"
2,"B","Biopharmaceutics",
13,"M","Presubmission",
14,"N","Approval",
16,"P","Periodic Safety Report",
19,"S","Supplement",
25,"Y","Annual Report",
1902,"SB","SBA",
1903,"SC","Chemistry",
1906,"SF","Final Printed Labeling (MarkIV)",
1912,"SL","Labeling",
1915,"SO","Other",
1919,"SS","Microbiology",
2001,"TA","Tentative Approval",
19051,"SE1","New or Modified Indication",
19052,"SE2","New Dosage Regimen",
19053,"SE3","New Route of Administration",
19054,"SE4","Comparative Efficacy Claim",
19055,"SE5","Patient Population Altered",
19056,"SE6","OTC Labeling",
19057,"SE7","Accelerated Approval",
19058,"SE8","Efficacy Supplement with Clinical Data to Support",
190301,"SCA","Packaging Addition",
190302,"SCB","Facility Addition",
190303,"SCC","Supplier Addition",
190304,"SCD","Packager Addition",
190305,"SCE","Expiration Date Change",
190306,"SCF","Formulation Revision",
190307,"SCG","Chemistry Generic",
190309,"SCI","Chemistry in Effect",
190313,"SCM","Manufacturing Change or Addition",
190316,"SCP","Package Change",
190317,"SCQ","Chemistry New Strength",
190318,"SCR","Manufacturing Revision",
190319,"SCS","Control Supplement",
190324,"SCX","Chemistry Expedite",
190403,"SDC",,
190419,"SDS","Distributor",
190504,"SED","Efficacy (MarkIV)",
190506,"SEF",,
190519,"SES","General Efficacy (MarkIV)",
190616,"SFP","Final Printed Labeling - MarkIV",
191201,"SLA","Labeling (MarkIV)",
191209,"SLI","Labeling in Effect",
191213,"SLM","Labeling (MarkIV)",
191218,"SLR","Labeling Revision",
191219,"SLS","Labeling (MarkIV)",
191224,"SLX","Labeling Expedite",
191501,"SOA","Other Amendment",
191604,"SPD","Practioner Draft Labeling",
191606,"SPF","Practioner Draft Labeling",
191803,"SRC","Resubmission - Chemistry (MarkIV)",
191805,"SRE","Resubmission - Efficacy (MarkIV)",
191815,"SRO","Resubmission - Other (MarkIV)",
191901,"SSA","Supplement Amendment (MarkIV)",
191916,"SSP","Supplement Pediatric (MarkIV)",
191918,"SSR","Supplement Resubmission (MarkIV)",
191923,"SSW","Supplement Withdrawal (MarkIV)",
